http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001522881-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12G3-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12G3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12G3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12G3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 |
filingDate | 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2001-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2001522881-A |
titleOfInvention | Composition comprising ingredients for a beverage having a delayed aversive effect |
abstract | (57) [Summary]nThe invention relates to the field of medicine and can be used in the preparation of compositions for reducing the negative effects caused in an organism by ethyl alcohol or by toxic products from its oxidation. . The composition contains ascorbic acid and / or its derivatives, sugar, salt and hydroalcoholic solution, the components being selected in the following proportions per 1000 decaliters of the final product: 3-20 kg of acid and / or derivative thereof, 150-250 kg of sugar, 5-20 kg of salt, the balance of which consists of a 20-40% standard concentration aqueous alcohol solution. The ascorbic acid derivative of this composition comprises dehydroascorbic acid, an alkali metal or alkaline earth metal salt of ascorbic acid or ethyl ascorbic acid. These esters are selected from the group consisting of ascorbic acid 2,6-diethyl ester, ascorbic acid 3,6-diethyl ester, ascorbic acid 2,3-diethyl ester and ascorbic acid 1-ethyl ester. The composition has a delayed aversive effect and can be used for the prevention of the development of alcoholism, wherein the composition is intended to treat alcoholism on its own. Can also be used. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017169100-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017176168-A |
priorityDate | 1997-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.